David Laplaud

12.4k total citations
117 papers, 4.1k citations indexed

About

David Laplaud is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, David Laplaud has authored 117 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 39 papers in Immunology and 21 papers in Neurology. Recurrent topics in David Laplaud's work include Multiple Sclerosis Research Studies (61 papers), T-cell and B-cell Immunology (25 papers) and Immunotherapy and Immune Responses (23 papers). David Laplaud is often cited by papers focused on Multiple Sclerosis Research Studies (61 papers), T-cell and B-cell Immunology (25 papers) and Immunotherapy and Immune Responses (23 papers). David Laplaud collaborates with scholars based in France, United States and United Kingdom. David Laplaud's co-authors include Sophie Brouard, Emmanuelle Le Page, Laure Michel, Sandrine Wiertlewski, Marc Coustans, Jean‐Paul Soulillou, J. de Sèze, Gilles Edan, Marion Salou and Sandra Vukusic and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

David Laplaud

111 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Laplaud France	37	2.0k	1.3k	986	591	497	117	4.1k
Suzanne Hodgkinson Australia	30	1.1k 0.6×	1.2k 0.9×	449 0.5×	371 0.6×	316 0.6×	110	2.9k
Zsolt Illés Hungary	38	1.8k 0.9×	2.1k 1.6×	1.4k 1.4×	594 1.0×	968 1.9×	217	5.4k
Eliécer Coto Spain	45	461 0.2×	1.6k 1.2×	550 0.6×	571 1.0×	3.3k 6.6×	304	8.1k
Bibiana Bielekova United States	38	2.9k 1.5×	3.1k 2.3×	856 0.9×	1.0k 1.7×	1.1k 2.2×	103	6.0k
Niall Tubridy Ireland	32	2.2k 1.1×	1.1k 0.8×	832 0.8×	481 0.8×	570 1.1×	124	4.6k
Oluf Andersen Sweden	39	2.6k 1.3×	860 0.6×	1.5k 1.5×	782 1.3×	2.0k 4.0×	135	5.9k
Stephen Sawcer United Kingdom	40	2.5k 1.3×	2.5k 1.9×	1.7k 1.8×	658 1.1×	1.6k 3.2×	130	7.1k
Stephen Lake United States	28	2.1k 1.1×	964 0.7×	772 0.8×	790 1.3×	1.1k 2.2×	66	5.6k
H L Weiner United States	27	1.1k 0.6×	2.0k 1.5×	334 0.3×	416 0.7×	411 0.8×	47	4.0k
Patrice H. Lalive Switzerland	34	1.0k 0.5×	940 0.7×	1.0k 1.0×	321 0.5×	491 1.0×	140	3.3k

Countries citing papers authored by David Laplaud

Since Specialization

Citations

This map shows the geographic impact of David Laplaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Laplaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Laplaud more than expected).

Fields of papers citing papers by David Laplaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Laplaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Laplaud. The network helps show where David Laplaud may publish in the future.

Co-authorship network of co-authors of David Laplaud

This figure shows the co-authorship network connecting the top 25 collaborators of David Laplaud. A scholar is included among the top collaborators of David Laplaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Laplaud. David Laplaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cruciani, Carolina, Marco Puthenparampil, María José Docampo, et al.. (2025). Intrathecal Anti-Akkermansia muciniphila IgG Responses in Multiple Sclerosis Patients Linked to CSF Immune Cells and Disease Activity. Journal of Clinical Medicine. 14(16). 5771–5771.

Ruet, Aurélie, P. Duffau, Guillaume Mathey, et al.. (2024). Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohort. Brain and Behavior. 14(9). e3443–e3443. 3 indexed citations

Linnerbauer, Mathias, Tobias A. Beyer, Hania Kébir, et al.. (2023). PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nature Communications. 14(1). 5555–5555. 33 indexed citations

Roulois, David, Simon Léonard, Alexandra Garcia, et al.. (2022). Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature. Neurology Neuroimmunology & Neuroinflammation. 9(6). 15 indexed citations

Drouin, Pierre, Aymeric Stamm, Nicolas Philippe, et al.. (2022). Gait impairment monitoring in multiple sclerosis using a wearable motion sensor. HAL (Le Centre pour la Communication Scientifique Directe). 5(1). 1 indexed citations

Michaud, Audrey, Sandra Vukusic, Emmanuelle Le Page, et al.. (2022). COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients. Journal of Neurology. 269(10). 5571–5581. 5 indexed citations

Manchon, Éric, David Laplaud, Sandra Vukusic, et al.. (2022). Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study. Multiple Sclerosis and Related Disorders. 68. 104109–104109. 9 indexed citations

Page, Emmanuelle Le, Sandra Vukusic, Gilles Edan, et al.. (2022). Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients. Multiple Sclerosis and Related Disorders. 68. 104122–104122. 2 indexed citations

Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. Multiple Sclerosis Journal. 26. 49–50. 84 indexed citations

10.

Renand, Amédée, Iñaki Cervera-Marzal, Laurine Gil, et al.. (2020). Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. Journal of Hepatology. 73(6). 1379–1390. 51 indexed citations

11.

Bove, Riley, Kelsey A. Rankin, Chao Zhao, et al.. (2019). Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Multiple Sclerosis Journal. 26(11). 1410–1419. 35 indexed citations

12.

Tourbah, Ayman, Christine Lebrun‐Frénay, Gilles Edan, et al.. (2016). 24-Month-Treatment with-MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of the MS-SPI Trial Extension Phase (S49.004). Neurology. 86(16_supplement). 1 indexed citations

13.

Bodiguel, Eric, Caroline Bensa, David Brassat, et al.. (2014). Multiple sclerosis and pregnancy. Revue Neurologique. 170(4). 247–265. 15 indexed citations

14.

Pettré, Ségolène, Laureline Berthelot, Alexandra Garcia, et al.. (2010). T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis. Brain. 133(6). 1622–1636. 19 indexed citations

15.

Leray, Emmanuelle, Jacqueline Yaouanq, Emmanuelle Le Page, et al.. (2010). Evidence for a two-stage disability progression in multiple sclerosis. Brain. 133(7). 1900–1913. 406 indexed citations

16.

Berthelot, Laureline, Patrick Miqueu, Ségolène Pettré, et al.. (2010). Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing–remitting multiple sclerosis patients. Clinical Immunology. 135(1). 33–42. 4 indexed citations

17.

Zhang, Xin, Laureline Berthelot, David Laplaud, et al.. (2008). Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clinical Immunology. 130(2). 133–144. 104 indexed citations

18.

Michel, Laure, Laureline Berthelot, Ségolène Pettré, et al.. (2008). Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis. Journal of Clinical Investigation. 118(10). 3411–9. 89 indexed citations

19.

Berthelot, Laureline, David Laplaud, Ségolène Pettré, et al.. (2008). Blood CD8⁺ T cell responses against myelin determinants in multiple sclerosis and healthy individuals. European Journal of Immunology. 38(7). 1889–1899. 40 indexed citations

20.

Laplaud, David, Emmanuelle Leray, P. Barrière, Sandrine Wiertlewski, & T. Moreau. (2006). Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology. 66(8). 1280–1281. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact